Literature DB >> 9204342

MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis.

C Muhle1, E Reinhold-Keller, C Richter, G Duncker, A Beigel, G Brinkmann, W L Gross, M Heller.   

Abstract

The purpose of this study was to evaluate diagnostic MRI criteria in Wegener's granulomatosis of the nasal cavity, the paranasal sinuses and orbits. Between March 1991 and January 1996, 62 patients with biopsy-proven Wegener's granulomatosis were studied with T1- and T2-weighted spin-echo (SE) sequences. In 32 patients coronal postcontrast T1-weighted images were obtained. Mucosal thickening of the nasal cavity and paranasal sinuses was demonstrated as high-intensity lesions on T2-weighted SE sequences in 57 patients (92%). Of this group, inflammatory granulomatous tissue was found on biopsy in 30 patients (48%) in the nasal cavity and in 4 patients (6%) in the paranasal sinuses. In 23 patients (37%) biopsy revealed unspecific inflammatory changes without evidence of granulomatous tissue. In 14 patients (23%) granulomas were depicted as low-signal intensity lesions on T1- and T2-weighted SE sequences in the paranasal sinuses and orbits. In 5 patients (8%) osseous destruction was found. After gadolinium injection, 12 of 14 granulomas showed inhomogeneous signal enhancement. In two granulomas no enhancement was found. The MRI technique is helpful in the diagnosis of patients with Wegener's granulomatosis. In the initial inflammatory process of Wegener's granulomatosis, it is not possible to differentiate between mucosal inflammation and granulomatous tissue in MRI. In the later stage of granulomatous transformation, granulomas can be depicted as low-signal-intensity lesions. Therefore, Wegener's granulomatosis should be included in the differential diagnosis of patients with low-signal-intensity lesions on T1- and T2-weighted SE sequences of the nasal cavity, paranasal sinuses and orbits.

Entities:  

Mesh:

Year:  1997        PMID: 9204342     DOI: 10.1007/s003300050206

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

Review 1.  Wegener's granulomatosis and the Churg-Strauss syndrome.

Authors:  J L Faul; W G Kuschner
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

2.  Unusual CT and MR findings of inflammatory pseudotumor in the parapharyngeal space: case report.

Authors:  K Nakayama; Y Inoue; T Aiba; K Kono; K Wakasa; R Yamada
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

Review 3.  [Early diagnosis of vasculitides].

Authors:  B Hellmich; P Lamprecht; P M Aries; W L Gross
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

Review 4.  Radiological imaging of inflammatory lesions in the nasal cavity and paranasal sinuses.

Authors:  H B Eggesbø
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 5.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

6.  [Imaging procedures in rheumatology: imaging in vasculitis].

Authors:  W A Schmidt; M Both; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2006-11       Impact factor: 1.372

7.  Bilateral dacryoadenitis as initial presentation of a locally aggressive and unresponsive limited form of orbital granulomatosis with polyangiitis.

Authors:  Rute Lopes Caçola; Sandra Alves Morais; Rui Carvalho; Rui Môço
Journal:  BMJ Case Rep       Date:  2016-05-11

Review 8.  Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?

Authors:  Antje Mueller; Konstanze Holl-Ulrich; Wolfgang L Gross
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 9.  [Wegener's granulomatosis and microscopic polyangiitis].

Authors:  K de Groot; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

Review 10.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.